1
|
Montrimas A, Rinkevičiūtė J, Žemaitienė R. Posterior capsule opacification treatment using Nd: YAG laser capsulotomy: 36 months retrospective analysis. BMC Ophthalmol 2025; 25:197. [PMID: 40211198 PMCID: PMC11987388 DOI: 10.1186/s12886-025-04023-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2025] [Accepted: 03/27/2025] [Indexed: 04/12/2025] Open
Abstract
BACKGROUND The study aimed to identify factors influencing the time from cataract surgery to PCO treatment with Neodymium: Yttrium-Aluminium-Garnet (Nd: YAG) laser. METHODS For PCO risk factors analysis the retrospective study included 1045 eyes treated for PCO using Nd: YAG laser capsulotomy in the Hospital of Lithuanian University of Health Sciences (HLUHS) Kaunas Clinics with reduced best-corrected distance visual acuity (BCDVA) and opacity in the central 3 mm zone. Eyes with no comorbidities were categorized into groups according to the intraocular lense (IOL) implanted and the time from cataract operation to Nd: YAG capsulotomy was compared. Tests used for statistical analysis: Shapiro-Wilk, Kruskal-Wallis, Mann-Whitney, one-way independent ANOVA, Pearson's or Spearman's correlation coefficient, and multivariable linear regression. RESULTS A total of 918 patients (1045 eyes) were included. The median time from cataract surgery to capsulotomy was 39.0 (27.4-54.6) months (min. 2; max. 174), did not differ between men and women, and was shorter for junior surgeons (25.8 (19.8-35.1) months) compared to senior surgeons (39.6 (27.8-55.3) months) (p < 0.001). Seven factors affecting the time from cataract surgery to Nd: YAG capsulotomy were found: IOL model, surgeon's experience, BCDVA after surgery, capsular tension ring, pseudoexfoliation, BCDVA before capsulotomy and exudative age-related macular degeneration (adjusted R2 = 0.452; p < 0.001). The IOL model was the only factor with a strong correlation. The median time from cataract surgery to capsulotomy differed between all IOL groups: Acriva UD613 group 31.5 (23.0-38.0) months, Johnson&Johnson Tecnis ZCB00 group 41.0 (33.5-66.5) months, Bausch&Lomb Envista MX60 group 45.0 (38.5-54.5) months, and Alcon Acrysof IQ SN60WF group 53.0 (41.5-79.5) months. CONCLUSIONS The IOL model seems to have the greatest influence on the time from cataract surgery to Nd: YAG capsulotomy. Acrylic hydrophobic IOLs with a square optical edge have different times from cataract surgery to Nd: YAG capsulotomy. Hydrophobic acrylic IOL seems to have a longer time from cataract surgery to Nd: YAG capsulotomy compared to hydrophilic acrylic IOL with a hydrophobic surface.
Collapse
Affiliation(s)
- Andrius Montrimas
- Department of Ophthalmology, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, Kaunas, 50161, Lithuania.
- Department of Ophthalmology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania.
| | - Jorė Rinkevičiūtė
- Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - Reda Žemaitienė
- Department of Ophthalmology, Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences, Kaunas, 50161, Lithuania
- Department of Ophthalmology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania
| |
Collapse
|
2
|
Levinger E, Ostrovsky M, Friehmann A, Elhaddad O, Tole D, Darcy K, Leadbetter D, Tuuminen R, Goldberg M, Achiron A. Pseudophakic cystoid macular oedema and posterior capsular opacification rates after combined phaco-trabeculectomy vs. phaco alone. Acta Ophthalmol 2025; 103:115-120. [PMID: 39394695 PMCID: PMC11704849 DOI: 10.1111/aos.16766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2024] [Accepted: 09/14/2024] [Indexed: 10/14/2024]
Abstract
PURPOSE To assess the risk for pseudophakic cystoid macular oedema (PCME) and posterior capsular opacification (PCO) associated with combined cataract surgery and trabeculectomy compared to cataract surgery alone. METHODS Data analysis of subjects who underwent routine cataract surgery without and with concomitant trabeculectomy at the Department of Ophthalmology, Bristol Eye Hospital, the UK, between January 2008 and December 2017. Odds ratios (ORs) for PCME between the types of surgeries were calculated using univariate and multivariate regression analysis. Multivariate Cox regression controlling for age and gender was used to estimate the hazard ratio (HR) for neodymium-doped yttrium aluminium garnet (Nd:YAG) laser capsulotomies. RESULTS This study included 56 973 cataract surgeries without and 288 with concomitant trabeculectomy (phaco-trab) with a mean follow-up time of 6.9 ± 4.2 years. Baseline variables (age and gender, diabetes, pseudoexfoliation, use of pupil expansion device and postoperative follow-up time) were comparable between the groups. Postoperative rates of PCME remained non-significant between the cataract surgery and phaco-trabe groups both in uni- and multi-variate analysis (OR 0.347, 95%CI 0.049-2.477, p = 0.291). Furthermore, in Cox regression analysis adjusted for the patients' age and gender, Nd:YAG laser capsulotomy rates remained non-significant between the cataract surgery and phaco-trabe groups (HR 1.250, 95%CI 0.883-1.769, p = 0.209). CONCLUSIONS In our large cohort study, combining trabeculectomy with cataract surgery did not predispose to an increased PCME or Nd:YAG laser capsulotomy rates.
Collapse
Affiliation(s)
- Eliya Levinger
- Tel Aviv Sourasky Medical CenterTel AvivIsrael
- School of MedicineTel Aviv UniversityTel AvivIsrael
| | - Michael Ostrovsky
- Tel Aviv Sourasky Medical CenterTel AvivIsrael
- School of MedicineTel Aviv UniversityTel AvivIsrael
| | - Asaf Friehmann
- School of MedicineTel Aviv UniversityTel AvivIsrael
- Ophthalmology DepartmentMeir Medical CenterKfar SabaIsrael
| | - Omar Elhaddad
- University Hospitals Bristol and Weston NHS Foundation TrustBristol Eye HospitalBristolUK
- Faculty of MedicineAlexandria UniversityAlexandriaEgypt
| | - Derek Tole
- University Hospitals Bristol and Weston NHS Foundation TrustBristol Eye HospitalBristolUK
| | - Kieren Darcy
- University Hospitals Bristol and Weston NHS Foundation TrustBristol Eye HospitalBristolUK
| | | | - Raimo Tuuminen
- Department of OphthalmologyKymenlaakso Central HospitalKotkaFinland
- Helsinki Retina Research Group, Faculty of MedicineUniversity of HelsinkiHelsinkiFinland
| | - Mordechai Goldberg
- Glaucoma Service, Ophthalmology DepartmentShaare Zedek Medical CenterJerusalemIsrael
| | - Asaf Achiron
- Tel Aviv Sourasky Medical CenterTel AvivIsrael
- School of MedicineTel Aviv UniversityTel AvivIsrael
| |
Collapse
|
3
|
Belda JI, Placeres J, Elvira JC, Puig X, Pérez-Vives C, Zou M, Yu J, Sun S, O’Boyle D. Five-Year Incidence of Nd:YAG Capsulotomy After Cataract Surgery with Different Single-Piece Monofocal Intraocular Lenses: A Follow-Up Study of 3955 Eyes. Clin Ophthalmol 2024; 18:1599-1605. [PMID: 38855011 PMCID: PMC11162221 DOI: 10.2147/opth.s441012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Accepted: 04/18/2024] [Indexed: 06/11/2024] Open
Abstract
Purpose To estimate the incidence of neodymium-doped yttrium aluminum garnet laser (Nd:YAG) capsulotomy up to five years after cataract surgery with different single-piece acrylic monofocal IOLs in a Spanish cohort. Patients and Methods Data were extracted from electronic medical records. Eligible participants were aged ≥65, had cataract surgery with one of five different acrylic monofocal IOLs (Alcon AcrySof, AJL LLASY60, Medicontur Bi-flex, IOL Tech Stabibag and Zeiss Asphina), and more than six months baseline data. Participants were followed up to five years from surgery and up to six months from Nd:YAG. The incidence of Nd:YAG was compared between the IOLs and multivariate analyses were conducted to identify predictors of Nd:YAG incidence at five-years after cataract surgery. Results The initial cohort included 9545 patients with 14,519 eyes (53% female, average age 75 years). Of those, 3955 eyes were available for analysis five years after cataract surgery. Throughout the five years post-surgery, Nd:YAG incidence was consistently lower with Alcon Acrysof IOLs than the other IOLs. At five years the Nd:YAG incidence rate for Alcon Acrysof was 8.8%. In comparison, the incidence was 47.4% for AJL LLASY60 (OR = 9.54, 95% CI [6.57, 13.84]), 44.3% for Zeiss Asphina (OR = 8.35, 95% CI [5.85, 11.94]) and 44.0% for IOL Tech Stabibag (OR = 8.02, 95% CI [4.60, 13.84]). Conclusion Alcon AcrySof IOLs have a consistently lower risk of Nd:YAG incidence over a long follow-up period after cataract surgery, highlighting the importance of IOL choice for patients' long-term outcomes.
Collapse
Affiliation(s)
- José I Belda
- Department of Ophthalmology, Hospital Universitario de Torrevieja, Alicante, Spain
- Visionker Eye Clinic, Alicante, Spain
| | - Javier Placeres
- Department of Ophthalmology, Hospital Universitario de Torrevieja, Alicante, Spain
- Visionker Eye Clinic, Alicante, Spain
| | - Juan C Elvira
- Department of Ophthalmology, Hospital Universitario del Vinalopó, Alicante, Spain
| | | | | | - Ming Zou
- IQVIA Real World Solutions, Basel, Switzerland
| | - Jing Yu
- IQVIA Real World Solutions, Basel, Switzerland
| | - Shaohui Sun
- IQVIA Real World Solutions, Basel, Switzerland
| | | |
Collapse
|
4
|
Lee Y, Kim JS, Kim BG, Hwang JH, Kang MJ, Lee JH. Comparison of the Incidence of Nd:YAG Laser Capsulotomy Based on the Type of Intraocular Lens. MEDICINA (KAUNAS, LITHUANIA) 2023; 59:2173. [PMID: 38138276 PMCID: PMC10744545 DOI: 10.3390/medicina59122173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/20/2023] [Revised: 12/07/2023] [Accepted: 12/13/2023] [Indexed: 12/24/2023]
Abstract
Background and Objectives: Posterior capsular opacification (PCO) is the most common long-term complication of successful cataract surgery and can cause visual impairment. We aimed to investigate the effects of intraocular lens (IOL) characteristics on PCO by comparing the incidence of neodymium-doped yttrium aluminum garnet (Nd:YAG) laser capsulotomy for different types of intraocular lenses. Materials and Methods: A retrospective analysis was performed on 2866 eyes that underwent cataract surgery between January 2010 and December 2017, with at least 5 years of follow-up. The IOLs used for surgery were the hydrophobic lenses SN60WF (Alcon, Fort Worth, TX, USA), ZCB00 (Johnson & Johnson Vision, Santa Ana, CA, USA), and MX60 (Bausch & Lomb, Rochester, NY, USA), and the hydrophilic lens MI60 (Bausch & Lomb, Rochester, NY, USA). We analyzed the incidence of Nd:YAG laser capsulotomy according to the type of IOL used. Results: The incidence of Nd:YAG laser capsulotomy was significantly higher with MI60 lenses (31.70%, 175/552 eyes) compared to SN60WF (7.90%, 113/1431 eyes), ZCB00 (10.06%, 64/636 eyes), and MX60 (10.57%, 13/123 eyes; p < 0.001) lenses. The incidence of Nd:YAG laser capsulotomy was significantly lower with the hydrophobic IOLs (8.68%, 190/2190 eyes) than with the hydrophilic IOL (31.70%, 175/552 eyes; p < 0.001). Over time, the rate of increase in the cumulative number of Nd:YAG laser capsulotomy cases was the highest with MI60. The cumulative rate of Nd:YAG laser capsulotomy during the first 3 years was 4.90% with SN60WF (70/1431 eyes), 6.76% with ZCB00 (43/636 eyes), 8.94% with MX60 (11/123 eyes), and 26.10% with MI60 (144/552 eyes) lenses. Conclusions: The incidence of PCO is influenced by the material of the IOLs. The hydrophilic IOL was associated with a higher rate of Nd:YAG laser capsulotomy than the hydrophobic IOLs, with a shorter time to Nd:YAG laser capsulotomy.
Collapse
Affiliation(s)
| | | | | | | | | | - Jee Hye Lee
- Department of Ophthalmology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul 01757, Republic of Korea; (Y.L.); (J.S.K.); (B.G.K.); (J.H.H.); (M.J.K.)
| |
Collapse
|
5
|
Icoz M, Tarım B, Icoz SGG. The effect of Nd:YAG Laser applied in the posterior capsule opacification on retinal and choroidal structures. Photodiagnosis Photodyn Ther 2023; 43:103653. [PMID: 37295662 DOI: 10.1016/j.pdpdt.2023.103653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Revised: 05/23/2023] [Accepted: 06/06/2023] [Indexed: 06/12/2023]
Abstract
PURPOSE To assess the effect of neodymium:yttrium-aluminum-garnet (Nd-YAG) laser procedure on the choroid and retina in patients who developed posterior capsular opacification (PCO) after cataract surgery. METHODS In this study, 32 eyes of 30 patients who underwent Nd:YAG laser treatment for PCO were evaluated. Visual acuity (VA), intraocular pressure (IOP), central macular thickness (CMT) with optical coherence tomography device (OCT), ganglion cell layer (GCL), inner plexiform layer (IPL), retinal nerve fiber layer (RNFL) and subfoveal choroidal thickness (SCT) were measured. Choroidal vascular index (CVI) was calculated from HD line images obtained by spectral domain OCT with the software Image J. RESULTS The mean age of the patients participating in the study was 60.1 ± 8.9 years. There was no significant difference in IOP, CMT, RNFL, GCL, IPL and SCT values in all comparisons before and after laser (p>0.05 for all values). While Nd:YAG laser pretreatment CVI was 63.2 ± 3.2%, it was 66.8 ± 2.9% at 1 week and 67.1 ± 2.6% at 1 month after laser treatment. A significant difference was detected in the comparison of pre-laser CVI and post-laser 1 week and 1 month CVI (p<0.05 for all values). DISCUSSION CVI was found to be significantly higher in the post-laser period in patients who underwent Nd:YAG laser. As far as the author knows, this study is the first research in the literature to evaluate this relationship. CVI can be used to evaluate choroidal vascular changes after Nd:YAG laser.
Collapse
Affiliation(s)
- Mehmet Icoz
- Department of Ophthalmology, Yozgat City Hospital, Erdoğan Akdağ Mah., Viyana Cad., 66100 Merkez, Yozgat, Turkey.
| | - Bilge Tarım
- Department of Ophthalmology, Ankara City Hospital, Ankara, Turkey
| | | |
Collapse
|
6
|
He W, Cheng K, Zhao L, Liu S, Huang Z, Zhang K, Du Y, Zhou X, Lu Y, Zhu X. Long-Term Outcomes of Posterior Capsular Opacification in Highly Myopic Eyes and Its Influencing Factors. Ophthalmol Ther 2023; 12:1881-1891. [PMID: 37138195 PMCID: PMC10287617 DOI: 10.1007/s40123-023-00711-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2022] [Accepted: 04/04/2023] [Indexed: 05/05/2023] Open
Abstract
INTRODUCTION The purpose of this study was to evaluate the long-term outcomes of posterior capsular opacification (PCO) in highly myopic eyes and its influencing factors. METHODS Patients undergoing phacoemulsification with intraocular lens implantation and followed up for 1-5 years were included in this prospective cohort study. The severity of PCO was evaluated using EPCO2000 software system, with the area of central 3.0 mm (PCO-3 mm) and within the capsulorhexis (PCO-C) both being analyzed. Percentage of eyes after Nd:YAG capsulotomy, as well as clinically significant PCO (defined as eyes with visual-impairing PCO or after capsulotomy), were also included as outcome variables. RESULTS A total of 673 highly myopic eyes [axial length (AL) ≥ 26 mm] and 224 control eyes (AL < 26 mm) were analyzed. The mean follow-up time was 34.0 ± 9.0 months. PCO was more severe in highly myopic eyes compared with controls with regard to higher EPCO scores (P < 0.001 for both PCO-3 mm and PCO-C), higher capsulotomy rate (P = 0.001), higher clinically significant PCO rate (P < 0.001) and shorter PCO-free survival time (P < 0.001). Extreme myopia (AL ≥ 28 mm) would further aggravate PCO in terms of higher EPCO scores (PCO-3 mm: P = 0.017; PCO-C: P = 0.013) and higher clinically significant PCO rate (P = 0.024) compared with other myopic eyes. In highly myopic eyes, AL [odds ratio (OR) 1.124, P = 0.004] and follow-up duration (OR 1.082, P < 0.001) were independent risk factors for clinically significant PCO after cataract surgery. CONCLUSION Highly myopic eyes had more severe PCO in the long term. Longer AL and follow-up duration were associated with higher risk of PCO. CLINICAL TRIAL REGISTRATION The study was registered at ClinicalTrials.gov (NCT03062085).
Collapse
Affiliation(s)
- Wenwen He
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Kaiwen Cheng
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Liangliang Zhao
- Department of Ophthalmology, The Second Hospital of Jilin Univesity, Changchun, 120021, People's Republic of China
| | - Shuyu Liu
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Zhiqian Huang
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Keke Zhang
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Yu Du
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Xingtao Zhou
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China
| | - Yi Lu
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China.
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China.
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China.
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China.
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China.
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China.
| | - Xiangjia Zhu
- Department of Ophthalmology, Eye and Ear, Nose and Throat, Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China.
- Eye Institute, Eye and Ear, Nose, and Throat, Hospital of Fudan University, Shanghai, 200031, People's Republic of China.
- NHC Key Laboratory of Myopia, Fudan University, Shanghai, People's Republic of China.
- Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, 200031, People's Republic of China.
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, People's Republic of China.
- State Key Laboratory of Medical Neurobiology, Shanghai, 200032, People's Republic of China.
| |
Collapse
|
7
|
Li X, Li J, Sun D, Ma T, Chen W, Ye Z, Li Z. Development and Validation of a Prediction Model for Nd:YAG Laser Capsulotomy: A Retrospective Cohort Study of 9768 eyes. Ophthalmol Ther 2023; 12:1893-1912. [PMID: 37133707 PMCID: PMC10287599 DOI: 10.1007/s40123-023-00723-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Accepted: 04/20/2023] [Indexed: 05/04/2023] Open
Abstract
INTRODUCTION Posterior capsular opacification (PCO) is the most common complication of cataract surgery. In this study, we develop a model to quantitatively predict the probability of Nd:YAG laser capsulotomy for vision-threatening PCO to improve the life quality of postoperative patients. METHODS A registry analysis of cataract procedures performed between the years 2010 and 2021. Following the screening of 16,802 patients (25,883 eyes), 9768 patients (eyes) were enrolled. The cohort was randomly divided into two groups: training (n = 6838) and validation (n = 2930). To identify relevant risk factors, univariate, multivariate, and Least Absolute Shrinkage and Selection Operator (LASSO) algorithm Cox regression analysis were employed, and a nomogram was created to demonstrate the prediction result. RESULTS At 5 years, the overall cumulative incidence of Nd:YAG laser capsulotomy was 12.0% (1169/9768). The following variables were included in the prediction model: sex [hazard ratio (HR) = 1.53, 95% CI 1.32-1.76], age (HR = 0.71, 95% CI 0.56-0.88), intraocular lens (IOL) material (HR = 2.65, 95% CI 2.17-3.24), high myopia (HR = 2.28, 95% CI 1.90-2.75), and fibrinogen (HR = 0.79, 95% CI 0.72-0.88). In the validation cohort, the area under the curve (AUC) of 1-, 3-, and 5-year predictions for Nd:YAG laser capsulotomy were 0.702, 0.691, and 0.688, respectively. For a subgroup of patients with high myopia, the protective effect of hydrophobic IOL disappeared (HR = 0.68, 95% CI 0.51-1.12, P = 0.127). CONCLUSION This model could predict the probability of Nd:YAG laser capsulotomy for vision-threatening PCO after cataract surgery by taking into account factors such as age, gender, IOL material, high myopia, and fibrinogen. Meanwhile, implantation of a hydrophobic IOL in individuals with high myopia did not demonstrate a protective impact against vision-threatening PCO.
Collapse
Affiliation(s)
- Xuanlong Li
- Medical School of Chinese PLA, Beijing, 100853 China
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Jinglan Li
- Medical School of Chinese PLA, Beijing, 100853 China
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Di Sun
- Medical School of Chinese PLA, Beijing, 100853 China
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Tianju Ma
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Wenqian Chen
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Zi Ye
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| | - Zhaohui Li
- Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, 100039 China
| |
Collapse
|
8
|
Nuijts RM, Bhatt U, Nanavaty MA, Roberts TV, Peterson R, Teus MA. Three-year multinational clinical study on an aspheric hydrophobic acrylic intraocular lens. J Cataract Refract Surg 2023; 49:672-678. [PMID: 36848238 PMCID: PMC10284131 DOI: 10.1097/j.jcrs.0000000000001173] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2022] [Revised: 01/23/2023] [Accepted: 02/16/2023] [Indexed: 03/01/2023]
Abstract
PURPOSE To present the results of a study investigating the 3-year effectiveness and safety of the Clareon single-piece intraocular lens (IOL). SETTING 19 multinational sites. DESIGN Prospective multicenter single-arm study. METHODS Patients were bilaterally implanted with Clareon IOLs. Assessments included uncorrected distance visual acuity, corrected distance visual acuity (CDVA), manifest refraction, tilt, decentration, applanation tonometry, and fundus examination, including glistenings and posterior capsule opacification (PCO) evaluation. The primary outcomes for effectiveness and safety were evaluated at 1 year and compared with ISO historical safety and performance endpoint (SPE) rates. Patients were followed for up to 3 years after implantation. RESULTS 424 eyes of 215 patients were implanted (n = 215 first eye, n = 209 second eye), and 183 patients completed the trial at 3 years (with 364 binocular and 1 monocular patient). At 1 year, the cumulative and persistent adverse event rates were below SPE targets, and 99.5% of eyes achieved a monocular CDVA of ≤0.3 logMAR (vs the SPE target of 92.5%). At 3 years, the mean monocular CDVA was -0.032, with 93.4% (341/365) of eyes achieving a CDVA of 0.1 logMAR or better, 100% of eyes presented with grade 0 glistenings ≤25 MV/mm 2 , and 92.9% of eyes (394/424) had either no PCO or clinically nonsignificant PCO. CONCLUSIONS This study supports the long-term safety and effectiveness of the Clareon IOL. The visual outcomes were excellent and stable over the 3-year study period, PCO rates were very low, and 100% of IOLs had grade 0 glistenings.
Collapse
Affiliation(s)
- Rudy M.M.A. Nuijts
- From the University Eye Clinic, Maastricht University Medical Center, Maastricht, the Netherlands (Nuijts); Vision Eye Institute, Melbourne, Victoria, Australia (Bhatt); Sussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom (Nanavaty); Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia (Roberts); Vision Eye Institute, Sydney, New South Wales, Australia (Roberts); Alcon Laboratories LLC, Fort Worth, Texas (Peterson); Hospital Universitario Principe de Asturias, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain (Teus)
| | - Uday Bhatt
- From the University Eye Clinic, Maastricht University Medical Center, Maastricht, the Netherlands (Nuijts); Vision Eye Institute, Melbourne, Victoria, Australia (Bhatt); Sussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom (Nanavaty); Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia (Roberts); Vision Eye Institute, Sydney, New South Wales, Australia (Roberts); Alcon Laboratories LLC, Fort Worth, Texas (Peterson); Hospital Universitario Principe de Asturias, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain (Teus)
| | - Mayank A. Nanavaty
- From the University Eye Clinic, Maastricht University Medical Center, Maastricht, the Netherlands (Nuijts); Vision Eye Institute, Melbourne, Victoria, Australia (Bhatt); Sussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom (Nanavaty); Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia (Roberts); Vision Eye Institute, Sydney, New South Wales, Australia (Roberts); Alcon Laboratories LLC, Fort Worth, Texas (Peterson); Hospital Universitario Principe de Asturias, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain (Teus)
| | - Timothy V. Roberts
- From the University Eye Clinic, Maastricht University Medical Center, Maastricht, the Netherlands (Nuijts); Vision Eye Institute, Melbourne, Victoria, Australia (Bhatt); Sussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom (Nanavaty); Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia (Roberts); Vision Eye Institute, Sydney, New South Wales, Australia (Roberts); Alcon Laboratories LLC, Fort Worth, Texas (Peterson); Hospital Universitario Principe de Asturias, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain (Teus)
| | - Rachael Peterson
- From the University Eye Clinic, Maastricht University Medical Center, Maastricht, the Netherlands (Nuijts); Vision Eye Institute, Melbourne, Victoria, Australia (Bhatt); Sussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom (Nanavaty); Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia (Roberts); Vision Eye Institute, Sydney, New South Wales, Australia (Roberts); Alcon Laboratories LLC, Fort Worth, Texas (Peterson); Hospital Universitario Principe de Asturias, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain (Teus)
| | - Miguel A. Teus
- From the University Eye Clinic, Maastricht University Medical Center, Maastricht, the Netherlands (Nuijts); Vision Eye Institute, Melbourne, Victoria, Australia (Bhatt); Sussex Eye Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom (Nanavaty); Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia (Roberts); Vision Eye Institute, Sydney, New South Wales, Australia (Roberts); Alcon Laboratories LLC, Fort Worth, Texas (Peterson); Hospital Universitario Principe de Asturias, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain (Teus)
| |
Collapse
|
9
|
Eggermont RL, Witteman AM, van Erkelens JA, Vermeulen K, Vunderink L, Reus NJ. Nd:YAG laser capsulotomy rates in the Netherlands: practice variation and association with physician practice styles. J Cataract Refract Surg 2023; 49:373-377. [PMID: 36729037 DOI: 10.1097/j.jcrs.0000000000001118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Accepted: 12/06/2022] [Indexed: 02/03/2023]
Abstract
PURPOSE To determine the practice variation in the rate of Nd:YAG laser capsulotomy within 1 year after cataract surgery and to identify possible associations with physician practice styles. SETTING All hospitals and private clinics in the Netherlands. DESIGN Retrospective observational study. METHODS In the national medical claims database, we identified all laser capsulotomies performed in the Netherlands within a year after cataract surgery in the years 2016 and 2017. Centers with the lowest and highest percentages of Nd:YAG laser capsulotomies were interviewed on their physician practice styles related to the development of posterior capsule opacification. RESULTS The incidence of Nd:YAG laser capsulotomy varied between 1.2% and 26.0% in 2016 (median 5.0%) and between 0.9% and 22.7% in 2017 (median 5.0%). The rate of capsulotomy was highly consistent over time for each center (Pearson correlation coefficient, 0.89, P < .001). In general, ophthalmology centers with a high rate of Nd:YAG laser capsulotomy more often did not (routinely) polish the posterior lens capsule, performed cortex removal with coaxial irrigation/aspiration (I/A, instead of bimanual), and more often used hydrophilic intraocular lenses (IOLs) (compared with only using hydrophobic IOLs). CONCLUSIONS We found a significant practice variation in performing Nd:YAG laser capsulotomy within 1 year after cataract surgery in the Netherlands. Routinely polishing the posterior capsule, using bimanual I/A, and the use of hydrophobic IOLs are associated with a lower incidence in Nd:YAG laser capsulotomy. Incorporating these practice styles may lower the practice variation and thus prevent added medical burden for the patient and decrease costs.
Collapse
Affiliation(s)
- Rogier L Eggermont
- From the Department of Ophthalmology, Amphia Hospital, Breda, the Netherlands (Eggermont, Reus); Department of Ophthalmology, The Rotterdam Eye Hospital, Rotterdam, the Netherlands (Eggermont); Department of Medical Advice, VGZ Health Insurance Company, Eindhoven, the Netherlands (Witteman); Vektis, Zeist, the Netherlands (van Erkelens); Department of Innovation and Advice, CZ, Health Insurance Company, Tilburg, the Netherlands (Vermeulen); Zorgverzekeraars Nederland, Zeist, the Netherlands (Vunderink)
| | | | | | | | | | | |
Collapse
|
10
|
Belda JI, Placeres J, Elvira JC, Puig X, Pérez-Vives C, Zou M, Sun S, Yu J, O’Boyle D. Costs and Healthcare Resource Utilization Associated with Posterior Capsule Opacification After Cataract Surgery with Five Different Intraocular Lenses: An Economic Analysis for Spain. Clin Ophthalmol 2022; 16:993-1001. [PMID: 35386615 PMCID: PMC8979752 DOI: 10.2147/opth.s349003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2021] [Accepted: 01/21/2022] [Indexed: 11/23/2022] Open
Abstract
Purpose Materials and Methods Results Conclusion
Collapse
Affiliation(s)
- José I Belda
- Hospital Universitario de Torrevieja, Torrevieja, Alicante, Spain
| | - Javier Placeres
- Hospital Universitario de Torrevieja, Torrevieja, Alicante, Spain
| | | | | | | | - Ming Zou
- IQVIA Real World Solutions, Basel, Switzerland
| | - Shaohui Sun
- IQVIA Real World Solutions, Basel, Switzerland
| | - Jing Yu
- IQVIA Real World Solutions, Basel, Switzerland
| | - Derek O’Boyle
- Alcon Laboratories Ireland Ltd., Cork, Ireland
- Correspondence: Derek O’Boyle, Alcon Laboratories Ireland Ltd., Cork, Ireland, Email
| |
Collapse
|